NFKB1 and Insulin resistance: Due to these metabolical changes, NFκB activation is reported to be associated with: insulin resistance (Assis et al., 2024), lipid metabolism dysregulation (Khalid et al., 2022), hypertension (Peng et al., 2016) and promotion of cardiovascular diseases and diabetic nephropathy (Lal et al., 2002), among others.